Apyx Medical Corporation
APYX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $13 | $11 | $9 | $14 |
| % Growth | 13.2% | 20.6% | -33.7% | – |
| Cost of Goods Sold | $5 | $4 | $4 | $5 |
| Gross Profit | $8 | $7 | $6 | $9 |
| % Margin | 64.4% | 62.3% | 60.1% | 63% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $1 | $9 | $8 | $11 |
| SG&A Expenses | $8 | $9 | $8 | $11 |
| Sales & Mktg Exp. | $7 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $10 | $9 | $12 |
| Operating Income | -$1 | -$3 | -$3 | -$3 |
| % Margin | -6.5% | -22.6% | -32.4% | -21.4% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$2 |
| Pre-Tax Income | -$2 | -$4 | -$4 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$4 | -$4 | -$5 |
| % Margin | -15.4% | -33.2% | -44% | -32.5% |
| EPS | 0 | -0.093 | -0.12 | -0.12 |
| % Growth | 100% | 22.7% | 0% | – |
| EPS Diluted | 0 | -0.093 | -0.12 | -0.12 |
| Weighted Avg Shares Out | 41 | 41 | 36 | 38 |
| Weighted Avg Shares Out Dil | 41 | 41 | 36 | 38 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $2 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$2 | -$3 | -$3 |
| % Margin | -2.6% | -19% | -27.7% | -19.5% |